Research ArticleAutoimmunity

First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases

+ See all authors and affiliations

Science Translational Medicine  21 Dec 2016:
Vol. 8, Issue 370, pp. 370ra184
DOI: 10.1126/scitranslmed.aaf2140

Log in to view full text


Navigate This Article